Gadolinium Lawyer

A recent study performed by dermatologist Whitney A. High, MD, MEng, Department of Dermatology at the University of Colorado, Denver and published in the Journal of the American Academy of Dermatology advanced the growing statistical evidence of the presence of gadolinium in the systems of patients suffering from Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy […]

[Read more →]

After the study performed by the Danish Medicines Agency in June 2006, the FDA decided to begin warning everyone about the possible connection of gadolinium-based agents and the onset of nephrogenic systemic fibrosis.  Studies are still being conducted to confirm that there is this connection; however, the FDA and GE Healthcare (the manufacturer of a […]

[Read more →]

For some time now, gadolinium has been hailed as a substance that tangibly aided doctors administering MRI’s and MRA’s. It’s a natural contrasting agent, which means that when it’s injected into the body, the MRI results will show clear and distinct delineations between healthy and not-so-healthy tissues.

However, as many news reports have recently detailed, gadolinium […]

[Read more →]

Gadolinium injections used as a diagnostic tool in Magnetic Resonance Imaging (MRI) are known to cause serious side effects to those who have kidney issues. Some cases show that even if you do not have kidney issues, you may be putting your health at risk when getting an MRI done.

When you are getting an MRI, […]

[Read more →]

Patients with renal failure are at an increased risk of developing NSF/NFD if they receive large amounts of Gadolinium-based contrast agents during an MRA.  Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD) is a rare, potentially life-threatening condition with no known cure.
Last year Medscape sited a study by the Danish Medicines Agency regarding this issue.  The […]

[Read more →]